Abstract
Smoking causes chronic obstructive pulmonary disease (COPD), but few controlled studies have tested anti-smoking treatments in COPD. With procedures likely to attract unmotivated persons we recruited 49 quite-ill, smoking COPD patients. During one or two daily home visits for 85 days, breath carbon monoxide (CO) and self-reports of daily smoking were obtained. Patients, given quit dates and nicotine gum (2-mg pieces, up to 30 per day), were assigned randomly to three groups: Experimentals were reinforced with lottery tickets for CO <10 ppm. Cigarette Self Report (CSR) patients were reinforced for reporting no smoking that day. Controls received non-contingent payments. Each group's mean CO level fell at the quit date. Thereafter, reinforced patients maintained significantly lower CO levels than Controls. Although many more 24-h abstentions occurred in the intervention period than in baseline, few patients sustained abstinence; the groups did not differ in that regard. Outcome was predicted by decisions to throw away cigarettes when intervention began, but not by motivation scales nor Fagerstrom dependence scores. Pay schedules apparently exaggerated self-reports of reduced smoking. Although results are statistically significant, there is still no proven, practical treatment for smoking in advanced COPD.
Similar content being viewed by others
References
American Thoracic Society (1987) Standards for the diagnosis and care of patients with chronic obstructive pulmonary disease (COPD) and asthma. Am Rev Respir Dis 136:225–244
Anthonisen NR (1989) Lung health study. Am Rev Respir Dis 140:871–872
Barlow RD, Thompson PA, Stone RB (1987) Simultaneous determination of nicotine, cotinine and five additional nicotine metabolites in the urine of smokers using precolumn derivatisation and high-performance liquid chromatography. J Chromatog 419:375–380
Braunwald E, Isselbacher KJ, Petersdorf RG, Wilson JD, Martin JB, Fauci AS (1991) Harrison's principles of internal medicine. McGraw-Hill, New York
British Thoracic Society (1983) Comparison of four methods of smoking withdrawal in patients with smoking related diseases. BMJ 286:595–597
Camilli AE, Burrows B, Knudson RJ, Lyle SK, Lebowitz MD (1987) Longitudinal changes in forced expiratory volume in one second in adults: effects of smoking and smoking cessation. Am Rev Respir Dis 135:794–799
Crowley TJ, Andrews AE, Cheney J, Zerbe G, Petty TL (1989) Carbon monoxide assessment of smoking in chronic obstructive pulmonary disease. Addic Behav 14:493–502
Crowley TJ, Macdonald MJ, Zerbe GO, Petty TL (1991) Reinforcing breath carbon monoxide reductions in chronic obstructive pulmonary disease. Drug Alcohol Depend 29:46–62
Daughton DM, Fix AJ, Kass I, Patil KD (1980) Smoking cessation among patients with chronic obstructive pulmonary disease (COPD). Addict Behav 5:125–128
Davis RM, Novotny TE (1989) The epidemiology of cigarette smoking and its impact on chronic obstructive pulmonary disease. Am Rev Respir Dis 140 [3 Pt 2]:S82-S84
DeGrandpre RJ, Bickel WK, Hughes JR, Higgins ST (1992) Behavioral economics of drug self-administration. III. A reanalysis of the nicotine regulation hypothesis. Psychopharmacology 108:1–10
Fletcher C, Peto R, Tinker C, Speizer FE (1976) The natural history of chronic bronchitis and emphysema: an eight-year study of early chronic obstructive lung disease in working men in London. Oxford University Press, Oxford
Hall RG, Hall SM, Sachs DPL, Benowitz NL (1984) Two-year efficacy and safety of rapid smoking therapy in patients with cardiac and pulmonary disease. J Consult Clin Psychol 52:574–581
Hall SM, Bachman J, Henderson JB, Barstow R, Jones RT (1983) Smoking cessation in patients with cardiopulmonary disease: an initial study. Addict Behav 8:33–42
Hall SM, Havassy BE, Wasserman DA (1990) Commitment to abstinence and acute stress in relapse to alcohol, opiates, and nicotine. J Consult Clin Psychol 58:175–181
Hall SM, Havassey BE, Wasserman DA (1991) Effects of commitment to abstinence, positive moods, stress, and coping on relapse to cocaine use. J Consult Clin Psychol 59:526–532
Heatherton TF, Kozlowski LT, Frecker RC, Fagerstrom KO (1991) The Fagerstrom test for nicotine dependence, a revision of the Fagerstrom Tolerance Questionnaire. Br J Addict 86:1119–1127
Higgins MW (1989) Chronic airways disease in the United States: trends and determinants. Chest 96 [3 Suppl]:328S-334S
Higgins MW (1991) Risk factors associated with chronic obstructive lung disease. Ann NY Acad Sci 624:7–17
Kenford SL, Fiore MC, Jorenby DE, Smith SS, Wetter D, Baker TB (1994) Predicting smoking cessation: who will quit with and without the nicotine patch. JAMA 271:589–594
Kronebusch K (1989) Smoking: human and economic costs. Cancer Invest 7:463–477
Kuller LH, Ockene JK, Townsend M, Browner W, Meilahn E, Wentworth DN (1989) The epidemiology of pulmonary function and COPD mortality in the Multiple Risk Factor Intervention Trial. Am Rev Respir Dis 140:S76-S81
Murray RP, Connet JE, Lauger GG, Voelker HT (1993) Error in smoking measures: effects of intervention on relations of cotinine and carbon monoxide to self-reported smoking. Am J Pub Health 83:1251–1257
O'Hara P, Grill J, Rigdon MA, Connett JE, Lauger GA, Johnston JJ (1993) Design and results of the initial intervention program for the Lung Health Study. Prev Med 22:304–315
Parviainen MT, Puhakainen EVJ, Laatikainen R, Savolainen K, Heranen J, Barlow RD (1990) Nicotine metabolites in the urine of smokers. J Chromatogr 525:193–202
Paxton R (1980) The effects of a deposit contact as a component in a behavioural programme for stopping smoking. Behav Res Ther 18:45–50
Paxton R (1981) Deposit contracts with smokers: varying frequency and amount of repayments. Behav Res Ther 19:117–123
Pederson LL (1982) Compliance with physician advice to quit smoking: a review of the literature. Prev Med 11:71–84
Pederson LL, Wanklin JM, Lefcoe NM (1991) The effects of counselling on smoking cessation among patients hospitalized with chronic obstructive pulmonary disease: a randomized clinical trial. Int J Addict 26:107–119
Postma DS, Sluiter HJ (1989) Prognosis of chronic obstructive pulmonary disease: the Dutch experience. Am Rev Respir Dis 140:S100-S105
Rand CS, Stitzer ML, Bigelow GE, Mead AM (1989) The effects of contingent payment and frequent workplace monitoring on smoking abstinence. Addict Behav 14:121–128
Rennard SI, Daughton D, Fujita J, Oehlerking MB, Dobson JR, Stahl MG, Robbins RA, Thompson AB (1990) Short-term smoking reduction is associated with reduction in measures of lower respiratory tract inflammation in heavy smokers. Eur Respir J 3:752–759
Rogot E, Hrubec Z (1989) Trends in mortality from chronic obstructive pulmonary disease among US veterans: 1954 to 1979. Am Rev Respir Dis 140:S69-S75
Rose G, Hamilton PJS (1978) A randomised controlled trial of the effect on middle-aged men of advice to stop smoking. J Epidemiol Commun Health 32:275–281
Sachs DPL (1991) Advances in smoking cessation treatment. In: Simmons DH (ed) Current pneumonology, vol 12. Mosby Year Book, St Louis, pp 139–198
Sachs DPL, Benowitz NL, Silver KJ (1988) Effective use of nicotine polacrilex (NicoretteTM) in patients with chronic obstructive pulmonary disease. In: Smoking and health 1987. Aoki M et al. (eds) Elsevier, Amsterdam
Sherrill DL, Lebowitz MD, Burrows B (1990) Epidemiology of chronic obstructive pulmonary disease. Clin Chest Med 11:375–387
Sirota AD, Curran JP, Habif V (1985) Smoking cessation in chronically ill medical patients. J Clin Psychol 41:575–579
Speizer FE, Fay ME, Dockery DW, Ferris BG (1989) Chronic obstructive pulmonary disease mortality in six US cities. Am Rev Respir Dis 140:S49-S55
SPSS Inc. (1990) SPSS advanced statistics user's guide. Chicago, Illinois
Stitzer ML, Bigelow GE (1982) Contingent reinforcement for reduced carbon monoxide levels in carbon monoxide levels in cigarette smokers. Addict Behav 7:403–412
Stitzer ML, Bigelow GE (1983) Contingent payment for carbon monoxide reduction: effects of pay amount. Behav Ther 14:647–656
Stitzer ML, Bigelow GE (1984) Contingent reinforcement for carbon monoxide reduction: within-subject effects of pay amount. J Appl Behav Anal 17:477–483
Stitzer ML, Bigelow GE (1985) Contingent reinforcement for reduced breath carbon monoxide levels: target-specific effects on cigarette smoking. Addict Behav 10:345–349
Stitzer ML, Rand CS, Bigelow GE, Mead AM (1986) Contingent payment procedures for smoking reduction and cessation. J Appl Behav Anal 19:197–202
Tashkin DP, Clark VA, Coulson AH et al. (1984) The UCLA population studies of chronic obstructive respiratory disease. VIII. Effects of smoking cessation on lung function: a prospective study of a free-living population. Am Rev Respir Dis 130:707–715
Tonnesen P, Fryd V, Hansen M, Helsted J, Gunnersen AB, Forchammer H, Stockner M (1988) Effect of nicotine chewing gum in combination with group counseling on the cessation of smoking. N Engl J Med 318:15–18
Velicer WF, Prochaska JO, Rossi JS, Snow MG (1992) Assessing outcome in smoking cessation studies. Psychol Bull 111:23–41
Vollmer WM, McCamant LE, Johnson LR, Buist AS (1990) Long-term reproducibility of tests of small airways fiunction: comparisons with spirometry. Chest 98:303–307
Wald NJ, Idle M, Boreham J, Bailey A (1981) Carbon monoxide in breath in relation to smoking and carboxyhaemoglobin levels. Thorax 36:366–369
Author information
Authors and Affiliations
Rights and permissions
About this article
Cite this article
Crowley, T.J., Macdonald, M.J. & Walter, M.I. Behavioral anti-smoking trial in chronic obstructive pulmonary disease patients. Psychopharmacology 119, 193–204 (1995). https://doi.org/10.1007/BF02246161
Received:
Revised:
Issue Date:
DOI: https://doi.org/10.1007/BF02246161